Literature DB >> 25995915

Crystal structure of 2-(1H-imidazol-4-yl)ethanaminium chloride.

Imene Belfilali1, Siham Yebdri1, Samira Louhibi1, Leila Boukli-Hacene1, Thierry Roisnel2.   

Abstract

The title mol-ecular salt, C5H10N3 (+)·Cl(-), was obtained as by-product in the attempted synthesis of a histamine derivative. The terminal amino group of the starting material is protonated. The Cimidazole-C-C-N(H3)(+) group in the cation is in an anti conformation with a torsion angle of 176.22 (10)°. In the crystal, cations and anions are linked via N-H⋯N and N-H-Cl hydrogen bonds, forming a two-dimensional network parallel to (10-1). A single weak C-H⋯Cl hydrogen bond completes a three-dimensional network.

Entities:  

Keywords:  chloride Ion; crystal structure; histamine; hydrogen bonding; imidazole; protonation

Year:  2015        PMID: 25995915      PMCID: PMC4420062          DOI: 10.1107/S2056989015006866

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Related literature

For the biological and pharmacological applications of histamine derivatives, see: Barnes et al. (2001 ▸); Schwartz et al. (1991 ▸); Bachert et al. (1998 ▸); Emanuel et al. (1999 ▸); Apáti et al. (2012 ▸). For a study of a histamine copper(II) chloride complex, see: Belfilali et al. (2015 ▸). For the general chemistry of transition metal ions with histamine, see: Mikulski et al. (2012 ▸); Kowalik-Jankowska et al. (2010 ▸); Selmeczi et al. (2012 ▸). For a related structure, see: Prout et al. (1974 ▸).

Experimental

Crystal data

C5H10N3 +·Cl− M = 147.61 Monoclinic, a = 4.5840 (2) Å b = 9.1614 (3) Å c = 17.3114 (5) Å β = 91.682 (1)° V = 726.69 (4) Å3 Z = 4 Mo Kα radiation μ = 0.44 mm−1 T = 150 K 0.41 × 0.13 × 0.08 mm

Data collection

Bruker APEXII diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2006 ▸)’ T min = 0.868, T max = 0.965 5568 measured reflections 1645 independent reflections 1494 reflections with I > 2σ(I) R int = 0.033

Refinement

R[F 2 > 2σ(F 2)] = 0.028 wR(F 2) = 0.076 S = 1.08 1645 reflections 86 parameters H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.34 e Å−3 Δρmin = −0.21 e Å−3

Data collection: APEX2 (Bruker, 2006 ▸); cell refinement: SAINT (Bruker, 2006 ▸); data reduction: SAINT; program(s) used to solve structure: SIR97 (Altomare et al., 1999 ▸); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▸); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012 ▸) and PLATON (Spek, 2009 ▸); software used to prepare material for publication: WinGX publication routines (Farrugia, 2012 ▸) and CRYSCAL (T. Roisnel, local program). Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015006866/lh5756sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015006866/lh5756Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989015006866/lh5756Isup3.docx Click here for additional data file. . DOI: 10.1107/S2056989015006866/lh5756fig1.tif The mol­ecular structure of the title compound. Displacement ellipsoids are drawn at the 50% probability level. Click here for additional data file. . DOI: 10.1107/S2056989015006866/lh5756fig2.tif Part of the crystal structure with hydrogen bonds shown as dashed lines. CCDC reference: 1051527 Additional supporting information: crystallographic information; 3D view; checkCIF report
C5H10N3+·ClF(000) = 312
Mr = 147.61Dx = 1.349 Mg m3
Monoclinic, P21/nMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ynCell parameters from 2978 reflections
a = 4.5840 (2) Åθ = 4.6–27.5°
b = 9.1614 (3) ŵ = 0.44 mm1
c = 17.3114 (5) ÅT = 150 K
β = 91.682 (1)°Prism, colourless
V = 726.69 (4) Å30.41 × 0.13 × 0.08 mm
Z = 4
Bruker APEXII diffractometer1494 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.033
CCD rotation images, thin slices scansθmax = 27.5°, θmin = 3.2°
Absorption correction: multi-scan (SADABS; Bruker, 2006)'h = −5→5
Tmin = 0.868, Tmax = 0.965k = −11→11
5568 measured reflectionsl = −19→22
1645 independent reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.028Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.076H atoms treated by a mixture of independent and constrained refinement
S = 1.08w = 1/[σ2(Fo2) + (0.0331P)2 + 0.246P] where P = (Fo2 + 2Fc2)/3
1645 reflections(Δ/σ)max = 0.001
86 parametersΔρmax = 0.34 e Å3
0 restraintsΔρmin = −0.21 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
N10.4106 (2)0.80020 (12)−0.01832 (6)0.0174 (2)
H1A0.31080.7313−0.04620.026*
H1B0.50290.8614−0.0510.026*
H1C0.28380.85210.01040.026*
C20.6308 (3)0.72762 (15)0.03395 (7)0.0174 (3)
H2A0.74970.80280.06130.021*
H2B0.76310.66750.00290.021*
C30.4835 (3)0.63146 (15)0.09277 (8)0.0192 (3)
H3A0.36150.69260.12620.023*
H3B0.35430.56050.06550.023*
C40.7051 (3)0.55095 (15)0.14180 (7)0.0169 (3)
N50.8253 (2)0.41984 (12)0.11844 (6)0.0184 (2)
C61.0162 (3)0.38371 (15)0.17436 (7)0.0197 (3)
H61.13340.29820.17410.024*
N71.0229 (3)0.48288 (14)0.23111 (7)0.0223 (3)
H71.124 (5)0.481 (2)0.2682 (14)0.05*
C80.8270 (3)0.58985 (16)0.21139 (8)0.0229 (3)
H80.78420.67470.24050.027*
Cl10.13058 (7)0.01456 (3)0.108958 (17)0.01841 (12)
U11U22U33U12U13U23
N10.0185 (5)0.0155 (6)0.0180 (5)−0.0019 (4)−0.0008 (4)−0.0004 (4)
C20.0152 (6)0.0180 (6)0.0190 (6)−0.0021 (5)−0.0022 (5)−0.0002 (5)
C30.0156 (6)0.0200 (7)0.0220 (7)−0.0008 (5)0.0007 (5)0.0009 (5)
C40.0160 (6)0.0180 (6)0.0169 (6)−0.0017 (5)0.0031 (5)0.0006 (5)
N50.0206 (5)0.0155 (5)0.0189 (5)−0.0016 (4)−0.0018 (4)−0.0006 (5)
C60.0218 (6)0.0176 (6)0.0197 (6)−0.0007 (5)−0.0012 (5)0.0015 (5)
N70.0238 (6)0.0268 (6)0.0161 (6)0.0001 (5)−0.0041 (5)−0.0009 (5)
C80.0252 (7)0.0233 (7)0.0202 (7)0.0034 (6)0.0008 (5)−0.0046 (6)
Cl10.02061 (18)0.01856 (18)0.01589 (19)−0.00105 (12)−0.00236 (12)−0.00087 (11)
N1—C21.4920 (16)C3—H3B0.99
N1—H1A0.91C4—C81.3604 (18)
N1—H1B0.91C4—N51.3866 (17)
N1—H1C0.91N5—C61.3277 (16)
C2—C31.5196 (18)C6—N71.3379 (18)
C2—H2A0.99C6—H60.95
C2—H2B0.99N7—C81.3658 (18)
C3—C41.4985 (18)N7—H70.78 (2)
C3—H3A0.99C8—H80.95
C2—N1—H1A109.5C2—C3—H3B109.4
C2—N1—H1B109.5H3A—C3—H3B108
H1A—N1—H1B109.5C8—C4—N5109.20 (11)
C2—N1—H1C109.5C8—C4—C3128.79 (13)
H1A—N1—H1C109.5N5—C4—C3121.99 (11)
H1B—N1—H1C109.5C6—N5—C4105.21 (11)
N1—C2—C3111.03 (10)N5—C6—N7111.50 (12)
N1—C2—H2A109.4N5—C6—H6124.2
C3—C2—H2A109.4N7—C6—H6124.2
N1—C2—H2B109.4C6—N7—C8107.63 (11)
C3—C2—H2B109.4C6—N7—H7126.3 (16)
H2A—C2—H2B108C8—N7—H7126.1 (16)
C4—C3—C2110.96 (10)C4—C8—N7106.46 (12)
C4—C3—H3A109.4C4—C8—H8126.8
C2—C3—H3A109.4N7—C8—H8126.8
C4—C3—H3B109.4
N1—C2—C3—C4176.22 (10)C4—N5—C6—N70.21 (15)
C2—C3—C4—C893.03 (17)N5—C6—N7—C8−0.18 (16)
C2—C3—C4—N5−84.87 (15)N5—C4—C8—N70.06 (15)
C8—C4—N5—C6−0.16 (15)C3—C4—C8—N7−178.06 (12)
C3—C4—N5—C6178.11 (12)C6—N7—C8—C40.07 (16)
D—H···AD—HH···AD···AD—H···A
N1—H1A···N5i0.911.962.8508 (15)168
N1—H1B···Cl1i0.912.283.1557 (11)160
N1—H1C···Cl1ii0.912.393.2443 (11)157
N7—H7···Cl1iii0.78 (2)2.40 (2)3.1645 (12)168 (2)
C2—H2A···Cl1iv0.992.723.6974 (14)168
Table 1

Hydrogen-bond geometry (, )

DHA DHHA D A DHA
N1H1AN5i 0.911.962.8508(15)168
N1H1BCl1i 0.912.283.1557(11)160
N1H1CCl1ii 0.912.393.2443(11)157
N7H7Cl1iii 0.78(2)2.40(2)3.1645(12)168(2)
C2H2ACl1iv 0.992.723.6974(14)168

Symmetry codes: (i) ; (ii) ; (iii) ; (iv) .

  9 in total

Review 1.  Histamine and serotonin.

Authors:  P J Barnes
Journal:  Pulm Pharmacol Ther       Date:  2001       Impact factor: 3.410

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

Review 3.  Histaminergic transmission in the mammalian brain.

Authors:  J C Schwartz; J M Arrang; M Garbarg; H Pollard; M Ruat
Journal:  Physiol Rev       Date:  1991-01       Impact factor: 37.312

4.  Calcium signaling in pluripotent stem cells.

Authors:  Ágota Apáti; Katalin Pászty; Zsuzsa Erdei; Kornélia Szebényi; László Homolya; Balázs Sarkadi
Journal:  Mol Cell Endocrinol       Date:  2011-09-14       Impact factor: 4.102

5.  Coordination abilities of neurokinin A and its derivative and products of metal-catalyzed oxidation.

Authors:  Teresa Kowalik-Jankowska; Elzbieta Jankowska; Zbigniew Szewczuk; Franciszek Kasprzykowski
Journal:  J Inorg Biochem       Date:  2010-04-11       Impact factor: 4.155

6.  Histamine and the antiallergic antihistamines: a history of their discoveries.

Authors:  M B Emanuel
Journal:  Clin Exp Allergy       Date:  1999-07       Impact factor: 5.018

Review 7.  Histamine--a major role in allergy?

Authors:  C Bachert
Journal:  Clin Exp Allergy       Date:  1998-12       Impact factor: 5.018

8.  l-Alanylglycylhistamine dihydro-chloride.

Authors:  Katalin Selmeczi; Patrick Gizzi; Emmanuel Wenger; Bernard Henry
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-05-31

9.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  9 in total
  1 in total

1.  Crystal structure of 2-(1H-imidazol-3-ium-4-yl)ethanaminium dichloride, a re-determination.

Authors:  Samira Louhibi; Imene Belfilali; Leila Boukli-Hacene; Thierry Roisnel
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-10-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.